Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

29.30HKD
23 Aug 2019
Change (% chg)

HK$0.45 (+1.56%)
Prev Close
HK$28.85
Open
HK$28.85
Day's High
HK$29.30
Day's Low
HK$28.65
Volume
7,262,501
Avg. Vol
6,330,846
52-wk High
HK$41.05
52-wk Low
HK$25.70

Jiang, Xiuchang 

Mr. Jiang Xiuchang is Chief Financial Officer, Vice President of Sinopharm Group Co., Ltd. He joined the Company in May 2010 as the chief financial officer, and has been the vice president of the Company since July 2013. He has over 31 years of working experience, over 20 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Jiang obtained a bachelor’s degree in financial accounting from Zhongnan University of Economics and Law in July 1986, and graduated from the class for advanced studies of postgraduate courses in corporate management from the School of International Business Management of University of International Business and Economics in January 2005. Mr. Jiang was qualified as a senior economist and senior accountant. Mr. Jiang served at China National Pharmaceutical Group Co., Ltd. from July 1986 to March 2002, and was the deputy head of the department of information, reform office, finance department and deputy manager of the department of pharmacy. He was deputy head, head and chief financial officer of the finance department of China National Medicines Corporation Ltd. from March 2002 to May 2010. Mr. Jiang is currently the chairman of Sinopharm Holding Jiangxi Co., Ltd., Sinopharm Holding Shanxi Co., Ltd., Sinopharm Holding Inner Mongolia Co., Ltd., Sinopharm Holding Tianjin Co., Ltd. and Sinopharm Group Shanxi Co., Ltd. and China National Medicines Corporation Ltd., and the director of China National Accord Medicines Co., Ltd., Sinopharm Group Finance Co., Ltd., and the director and general manager of Sinopharm Holding Hong Kong Co., Ltd., and the executive director of Beijing Sinopharm Tianyuan Real Estate & Property Management Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017